PODD vs SPXC · P/E 34, rev $2.07B vs P/E 46, rev $1.98B
Insulet Corporation (PODD) versus SPX Corp (SPXC) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
SPX Corp (SPXC) is a building products & equipment company listed on NYSE.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported SPXC revenue for 2024-12-31 was $1.98B. Net income was $200.5M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. SPXC currently screens at market cap $12.06B and trailing P/E 46.0.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. SPXC currently screens at market cap $12.06B and trailing P/E 46.0.
Not investment advice. Open the PODD and SPXC stock pages for the full models.
Not investment advice.